Market Indices
Latest News
 |
Eloxx Pharmaceuticals, Inc. (ELOX) earnings is schedule to release on 2025-04-02. Following... April 1, 2025 |
| ||
| ||
| ||
|
Price Targets
from Leerink Partners issued a price target of $20.00 for TENX on 2025-03-10 10:22:00.The adjusted price target was set to $20.00.At the time of the announcement, TENX...
March 10, 2025 TENX -2.90%
Matthew Caufield from H.C. Wainwright issued a price target of $32.00 for SRZN on 2025-01-30 11:04:21.The adjusted price target was set to $32.00.At the time of the announcement,
January 30, 2025 SRZN -4.63%
Scott Buck from H.C. Wainwright issued a price target of $1.50 for WKSP on 2025-01-23 11:03:23.The adjusted price target was set to $1.50.At the time of the announcement,
January 23, 2025 WKSP 3.13%
Yatin Suneja from Guggenheim issued a price target of $45.00 for SRZN on 2025-01-03 11:15:22.The adjusted price target was set to $45.00.At the time of the announcement, SRZN...
January 3, 2025 SRZN -4.63%
Biren Amin from Piper Sandler issued a price target of $35.00 for CRBP on 2024-12-02 09:09:00.The adjusted price target was set to $35.00.At the time of the announcement,
December 2, 2024 CRBP -5.27%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| RSLS ReShape Lifesciences Inc. | 1.59
341.05% | ||||||||||||||||||
| TCRT Alaunos Therapeutics, Inc | 2.16
46.94% | ||||||||||||||||||
| SONM Sonim Technologies, Inc. | 2.96
38.32% | ||||||||||||||||||
| GCTK GlucoTrack, Inc. | 0.23
28.94% | ||||||||||||||||||
| EQ Equillium, Inc. | 0.50
28.42% | ||||||||||||||||||
| LXEH Lixiang Education Holding | 24.53
26.64% | ||||||||||||||||||
| NXU Nxu, Inc. | 3.38
26.59% | ||||||||||||||||||
| ADNWW Advent Technologies Holdi | 0.01
21.96% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape of fluctuating revenues and complex operating expenses, KKR navigates its financial journey with strategic investments and a commitment to transparency. Management emphasizes the importance of timely decision-making...
November 5, 2024 KKRS 0.34%
In the latest quarter, the company reported a revenue of 96, marking a 33 increase, while operating expenses rose slightly to 2,776. Despite these fluctuations, net income reached 1,096, reflecting...
November 5, 2024 CTBB 5.86%